Global Dialysis Concentrates Market, By Product (A.V. Fistula Needle, Dialysis Catheter, Dialyzer, Hemodialysis Bloodline and Tubing Set, Water Treatment System, Hemodialysis Machine, A.V. Access Graft, Dialysis Concentrates, Dialyzer Reprocessing Machine, Declotting Device, Introducer Sheath and Guidewire), Type (Haemodialysis Dialysis Concentrates, Peritoneal Dialysis Concentrates), End Use (Hospitals, Ambulatory Surgical Centres, Clinics, Others) – Industry Trends and Forecast to 2029.
Dialysis Concentrates Market Analysis and Size
Chronic kidney disease affects 10% of the global population, and over 2 million people receive dialysis yearly. The United States, Germany, Japan, Brazil, and Italy account for 80% of the 2 million procedures performed, while the rest of the world accounts for 20%. As a result, dialysis services are in high demand in middle-income countries. Furthermore, the rising prevalence of chronic kidney disease has contributed to the market's rapid expansion.
Data Bridge Market Research analyses that the dialysis concentrates market which was USD 2837.79 million in 2021, would rocket up to USD 4322.20 million by 2029, and is expected to undergo a CAGR of 5.40% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Dialysis Concentrates Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (A.V. Fistula Needle, Dialysis Catheter, Dialyzer, Hemodialysis Bloodline and Tubing Set, Water Treatment System, Hemodialysis Machine, A.V. Access Graft, Dialysis Concentrates, Dialyzer Reprocessing Machine, Declotting Device, Introducer Sheath and Guidewire), Type (Haemodialysis Dialysis Concentrates, Peritoneal Dialysis Concentrates), End Use (Hospitals, Ambulatory Surgical Centres, Clinics, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
B. Braun Melsungen AG (Germany), Nipro Europe Group Companies (Belgium), NIKKISO CO., LTD. (Japan), Fresenius Medical Care AG & Co. KGaA (Germany), Baxter (U.S.), Asahi Kasei Medical Co. Ltd (Japan), Medites Pharma, spol. s.r.o. (U.S.), Healthcare Partners MSO (U.S.), Dialife Group (Switzerland), Sandu Pharmaceuticals Limited (U.S.) and Farmasol (Turkey)
|
|
Market Opportunities
|
|
Market Definition
Dialysis concentrates are used to prepare a solution that helps to regulate electrolytes and remove metabolic waste products in haemodialysis Dialysis fluid is made up of purified water, glucose, and electrolytes and is used in the treatment of dialysis. Dialysis is a different form of treatment that can restore lost or inadequate kidney function.
Global Dialysis Concentrates Market Dynamics
Drivers
- Dialysis concentrates used in hospitals
Dialysis concentrates are used in hospitals due to the patient's needs to regulate the body's electrolyte balance, acid-base balance, and getting rid of metabolic waste products are taken into account when creating the dialysis concentrate. The haemodialysis concentrate solution is made to a precise P.H. value and is extremely efficient when used in operation. These factors will propel the market.
- Increasing patient population
An increasing patient population, the global dialysis concentrates market is growing steadily. Over the next decade, the patient population of home hemodialysis (HHD), peritoneal dialysis, and traditional in-center hemodialysis is expected to fuel the growth of the global dialysis concentrates the market. For instance, according to the United States Renal Data System (USRDS), between 2009 and 2019, the percentage of patients receiving home dialysis increased from 8.9% to 13.1%, a nearly 50% increase. In 2019, 13.1% of patients dialyzed at home, with 1.9% performing home hemodialysis and 11.2% performing peritoneal dialysis. These are some of the factors which will propel the market growth.
Opportunities
- Technological advancements
Research and development initiatives, as well as the development of advanced technology machines, are contributing to the growth of haemodialysis, increasing demand for dialysis concentrate in the region. For instance, Medtronic launched a dialysis machine for neonatal and paediatrics in the United States in December 2020. Quanta Dialysis Technologies Ltd, a British medical technology pioneer developing innovative dialysis products and services, also received 510(k) clearance from the U.S. Food and Drug Administration in January 2021 to market its small, simple, high-performance haemodialysis system SC+ in the U.S.
Restraints/Challenges
- Lack of awareness of kidney diseases
On the other hand, lack of awareness regarding kidney disease treatment modalities and low adoption of newly developed devices will obstruct the market's growth rate.
This dialysis concentrates market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the dialysis concentrates market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In October 2020, Diality, a privately held medical device company based in the United States, invested around USD 12.5 million in developing a portable hemodialysis system to address the unmet technology needs of the evolving dialysis industry. As a result of the high prevalence of kidney disease, the demand for hemodialysis is increasing, contributing to market growth.
- In April 2022, Rockwell Medical, Inc. announced an expanded partnership with DaVita Inc. to revise specific terms of its supply contracts with customers in order to stabilise its concentrates business. Rockwell Medical has been seeking to modify a few of the terms of its supply contracts with customers. These two contracts with DaVita are meant to put Rockwell Medical on a stronger financial basis so that its partners can supply patients receiving dialysis in their facilities.
Global Dialysis Concentrates Market Scope
The dialysis concentrates market is segmented on the basis of product, type and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- A.V. Fistula Needle
- Dialysis Catheter
- Dialyzer
- Hemodialysis
- Bloodline and Tubing Set
- Water Treatment System
- Hemodialysis Machine
- A.V. Access Graft
- Dialysis Concentrates
- Dialyzer Reprocessing Machine
- Declotting Device
- Introducer Sheath and Guidewire
Type
- Haemodialysis Dialysis Concentrates
- Peritoneal Dialysis Concentrates
End Use
- Hospitals
- Ambulatory Surgical Centres
- Clinics
- Others
Dialysis Concentrates Market Regional Analysis/Insights
The dialysis concentrates market is analysed and market size insights and trends are provided by country, product, type and end use as referenced above.
The countries covered in the dialysis concentrates market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the dialysis concentrates market due to the availability of several reimbursement policies for kidney disease treatment procedures in this region.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029, owing to the growing inventive and interdisciplinary technologies and products in this particular region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Dialysis Concentrates Market Share Analysis
The dialysis concentrates market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to dialysis concentrates market.
Some of the major players operating in the dialysis concentrates market are:
- B. Braun Melsungen AG (Germany)
- Nipro Europe Group Companies (Belgium)
- NIKKISO CO., LTD. (Japan)
- Fresenius Medical Care AG & Co. KGaA (Germany)
- Baxter (U.S.)
- Asahi Kasei Medical Co. Ltd (Japan)
- Medites Pharma spol. s.r.o. (U.S.)
- Healthcare Partners MSO (U.S.)
- Dialife Group (Switzerland)
- Sandu Pharmaceuticals Limited (U.S.)
- Farmasol (Turkey)
SKU-